scispace - formally typeset
I

Istvan Szanda

Researcher at St Thomas' Hospital

Publications -  12
Citations -  563

Istvan Szanda is an academic researcher from St Thomas' Hospital. The author has contributed to research in topics: Imaging phantom & Preclinical imaging. The author has an hindex of 8, co-authored 12 publications receiving 489 citations. Previous affiliations of Istvan Szanda include Budapest University of Technology and Economics & King's College London.

Papers
More filters
Journal ArticleDOI

Synthesis of 64CuII–Bis(dithiocarbamatebisphosphonate) and Its Conjugation with Superparamagnetic Iron Oxide Nanoparticles: In Vivo Evaluation as Dual‐Modality PET–MRI Agent

TL;DR: The synergistic combination of positron emission tomography (PET) and magnetic resonance imaging (MRI) is likely to become the next generation of dual-modality scanners in medical imaging, providing accurate diagnoses thanks to the sensitive and quantifiable signal of PET and the high soft-tissue resolution of MRI.
Journal ArticleDOI

National Electrical Manufacturers Association NU-4 Performance Evaluation of the PET Component of the NanoPET/CT Preclinical PET/CT Scanner

TL;DR: The large number of detector crystals, arranged with a fine pitch, results in excellent spatial resolution, which is the best reported for currently available commercial systems, and the absolute sensitivity is high over the field of view.
Journal ArticleDOI

Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.

TL;DR: In a model of metastatic breast cancer, this technique allows quantification of the biodistribution of a radiolabeled stealth liposomal nanomedicine containing alendronate that shows high uptake in primary tumors and metastatic organs.
Journal ArticleDOI

PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease

TL;DR: The trafficking of 64Cu in the brain after administration of 64 Cu-GTSM is significantly altered by AD-like pathology in the TASTPM mouse model, suggesting that 64Cu-G TSM PET imaging warrants clinical evaluation as a diagnostic tool for AD and possibly other neurodegenerative disorders.